Analyst Ratings for GT Biopharma Inc. (GTBP)
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 12/2/2024 | Roth/MKM | Jonathan Aschoff | New Coverage | Buy (N/A) |
11.00 (N/A) |
2.86 (0.41) |
-85.66% | Details |
| 5/24/2021 | H.C. Wainwright » Updated 9/13/2022 |
Robert Burns | New Coverage | Buy (N/A) |
5.00 (25.00) |
14.36 (0.41) |
-97.14% | Details |
![]() |
||||||||


